A Good Cancer research Bio company? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : A Good Cancer research Bio company?

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: B. Ino who wrote ()	8/30/1996 4:07:00 PM
From: Henry Niman	of 76

Check out Ligand Pharmaceuticals on this board or go to prnewswire.com and check out Ligand's company news for a year's worth of press releases. Their most advanced compounds that were developed in house are retinoids in phase 2/3 trials for a wide range of malignancies. They have many programs with many partners (PFE, GLX, AGN, ABT, AHP, SBE, & Sankyo) with more to come, but the most advanced cancer drug is Drolxifene which is in phase 3 trials for breast cancer (LGND has discovered a variety of anti-estrogens that will be entering additional trials, one this year in Europe and next year in the U.S). LGND, like many Biotechs, has pulled back from recent highs and should be an excellent long term play. Today you can get it at 12 3/8. A couple of months ago it was at 19 3/4. Henry

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next